Powerful Results, Promising Futures
 |
|
Click to view full-size version. |
83% of the subjects receiving MDMA-assisted psychotherapy in a pilot study no longer met the criteria for PTSD, and every patient who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements.
These results were published in the Journal of Psychopharmacology.
 |
|
Click to view full-size version. |
A long-term follow-up of patients who received MDMA-assisted psychotherapy revealed that overall benefits were maintained an average of 3.8 years later.
These extremely powerful results indicate a promising future for MDMA-assisted psychotherapy for PTSD and lay the groundwork for continued research into the safest and most effective ways to administer the treatment.
Presentation:
Michael Mithoefer, M.D.
San Francisco Veterans Administration Mental Health Services Grand Rounds
June 1, 2012
download | watch video
Results:
Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDMA-assisted psychotherapy: a prospective long-term follow-up study
Journal of Psychopharmacology 2013 | download
NEW A randomized, controlled pilot study of MDMA ({+/-}3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of treatment-resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Journal of Psychopharmacology 2013 | download
The safety and efficacy of MDMA-assisted psychotherapy in subjects with chronic, treatment-resistant PTSD: the first randomized controlled pilot study
Journal of Psychopharmacology 2011 | download
Resources:
Investigator's Brochure
download
Treatment Manual
download
Researchers Michael Mithoefer, MD
and Annie Mithoefer, BSN
Image: Flashnick Visuals
Download the brochure.
